RFK Jr. Faces Backlash Over FDA Rejection of Lifesaving Cancer Drug

President Trump’s Food and Drug Administration has decided not to approve a skin cancer treatment that could save lives, drawing backlash from doctors.On Wednesday, Secretary of Health and Human Services Robert F. Kennedy Jr. told Congress that he had nothing to do with the decision to withhold approval for Replimune’s drug, RP1, which treats melanoma, shifting responsibility to FDA Commissioner Dr. Marty Makary.  “This decision comes out of FDA, and we trust ​the process there. And I’...